Company: BDRX
Filing Date: 2025-12-08
Form Type: F-1/A
Source: 0001214659-25-017719
Chunk: 56

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-12-08
Form: F-1/A
Chunk 56
---
 rounded up to the nearest whole number. The number
of Depository Shares underlying the Series L Warrants to be issued will, at our election, either be rounded up to the nearest whole number
or we will pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the exercise price.

Fundamental Transactions.
In the event of a fundamental transaction, as described in the Series L Warrants and the Pre-Funded Warrants and generally including,
with certain exceptions, any reorganization, recapitalization or reclassification of our Depositary Shares, the sale, transfer or other
disposition of all or substantially all of our properties or assets, our consolidation or merger with or into another person, the acquisition
of more than 50% of our outstanding Depositary Shares or 50% of the voting power represented by our outstanding Depositary Shares, the
holders of the Series L Warrants and the Pre-Funded Warrants will be entitled to receive upon exercise of the warrants the kind and amount
of securities, cash or other property that the holders would have received had they exercised the warrants immediately prior to such fundamental
transaction. In addition, in the event of a fundamental transaction, we or the successor entity, at the request of a holder of Series
L Warrants, will be obligated to purchase any unexercised portion of such Series L Warrants in accordance with the terms of the Series
L Warrants.

Governing Law.
The Pre-Funded Warrants and the Series L Warrants are governed by New York law.

Form of Warrant.
The Pre-Funded Warrants and the Series L Warrants will be issued in certificated form to investors.

| 35 |

<div align='center'>DESCRIPTION OF SHARE CAPITAL</div>

The following describes our issued share capital, summarizes the material provisions of our Articles of Association and highlights certain differences in corporate law in the United Kingdom and the United States. This description of our share capital and summary of our Articles of Association is not complete, and is qualified by reference to our Articles of Association. You should read our Articles of Association, which are filed as an exhibit to the registration statement of which this prospectus forms a part, for the provisions that are important to you.

General

We are a public limited company
organized under the laws of England and Wales under registered number 09216368. Our registered office is 1 Caspian Point, Caspian Way,
Cardiff, CF10 4DQ, United